基可能是上部胃肠道癌症的危险因素:孟德尔随机化 (MR) 研究
Pengkhun Nov1,2, Wandan Li1,2, Duanyu Wang1,2
1Department of Radiation Oncology, Oncology Center, Zhujiang Hospital of Southern Medical University, No 253 Mid Gongye Ave, Haizhu District, Guangzhou 510282, Guangdong Province, China.
Ecancermedicalscience
|January 16, 2025
概括
基细胞数量升高是胃肠上部癌症的重要危险因素,包括食道和胃癌. 这项研究使用了门德尔的随机化来证实这种因果关系,突出了基细胞作为潜在的生物标志物.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
背景情况:
- 上部胃肠道 (UGI) 癌症,包括食道 (EC) 和胃 (GC) 癌症,是全球主要的健康问题.
- 之前的研究表明基细胞水平与UGI癌症风险之间存在联系,但因果关系需要进一步验证.
- 门德尔随机化 (MR) 是一种强有力的方法,用于调查外周循环血液细胞 (PCBC) 和UGI癌症之间的因果关系.
研究的目的:
- 为了研究周围循环血液细胞 (PCBC) 与患上上部胃肠道 (UGI) 癌症的风险之间的潜在因果关系.
- 为了确定特定的血细胞类型,特别是基细胞,是否作为食道癌 (EC) 和胃癌 (GC) 的因果风险因素.
主要方法:
- 使用公开可用的遗传数据进行了两样本的门德尔随机化 (MR) 分析.
- 逆方差加权和加权中位数方法用于MR分析.
- 进行了灵敏度分析,以评估异质性和性,确保发现的稳定性.
主要成果:
- 在较高的基细胞计数和食道癌 (EC) 和胃癌 (GC) 风险增加之间发现了显著的因果关系.
- 具体来说,高基细胞计数被确定为EC (OR = 1.416) 和GC (OR = 1.623) 的危险因素.
- 没有观察到埃索诺菲尔,单细胞,淋巴细胞或白细胞计数与UGI癌症风险之间存在显著的因果关系.
结论:
- 这项研究提供了强有力的证据,证明基细胞是上部胃肠道癌症的基本风险因素.
- 这些发现表明,基细胞水平可能是EC和GC风险评估中的一个有价值的指标.
- 进一步研究基细胞与UGI癌症相关性背后的生物学机制可能会导致新的预防和治疗策略.
相关概念视频
Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...


